Announced Fri, 24 Jul · 20:08 IST
Neogen Chemicals Rs 161 cr preferential issue funds fully utilised, no deviation
Compliance View source PDF
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹2055.00
prior close
₹2135.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.4-3.5-2.3-1.0——————————
Up moveDown movePending
AI summary
Neogen Chemicals raised Rs 161 crore via preferential issue of equity shares on April 18, 2026. CRISIL Ratings confirms no deviation in fund use for Q1 FY27 (quarter ended June 30, 2026). Funds fully utilised: Rs 100 cr invested in subsidiary Neogen Ionics for Pakhanjan project capex, Rs 21 cr for working capital, Rs 40 cr for general corporate purposes (SBI cash credit adjustment). This is the final monitoring report.
Likely market impact
Full deployment of raised funds with no deviation signals disciplined capital allocation. Positive for governance; the preferential issue account is now closed.